Clinical Trials Directory

Trials / Completed

CompletedNCT03951675

The Burden of Access in Duchenne Muscular Dystrophy in the US

The Burden of Access in Duchenne Muscular Dystrophy in the US. A Qualitative Assessment of the Impact of Access on the Lives of Families Affected by DMD and Their Healthcare Providers.

Status
Completed
Phase
Study type
Observational
Enrollment
57 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This study is being conducted to determine if DMD patients / families and healthcare providers experience burdens related to access, and if so, to identify them, and to determine life impacts to the patient, if any, of these burdens. Data from healthcare providers will be collected by an online survey and from patients/families by one on one telephone interview.

Detailed description

Patient/Parent Portion In this non-interventional study, DMD patients / parents of DMD patients will be interviewed to gather qualitative input, in the patient's voice, regarding challenges associated with access to medications, services and medical equipment, and how these burdens impact quality of life. Healthcare Provider Portion In this non-interventional study, healthcare providers who see patients with DMD and who deal with insurance issues on behalf of DMD patients will participate in an online survey designed to determine the burden associated with access to medications, services and medical equipment.

Conditions

Timeline

Start date
2019-06-18
Primary completion
2020-05-28
Completion
2020-05-28
First posted
2019-05-15
Last updated
2020-08-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03951675. Inclusion in this directory is not an endorsement.

The Burden of Access in Duchenne Muscular Dystrophy in the US (NCT03951675) · Clinical Trials Directory